Immunotherapy: Open Access
Open Access
ISSN: 2471-9552
ISSN: 2471-9552
Breast Cancer Immunotherapy holds many advantages over targeted treatments and conventional chemotherapy directed at the tumor itself. Drug in breast cancer immunotherapy is Herceptin.
It targets breast tumors that produce a protein called HER2. The side effects of this therapy are chills, pain, weakness, nausea, vomiting, diarrhoea. It mostly involves surgery depending upon its state and molecular characteristics.
Related Journals of Breast Cancer Immunotherapy
Immunotherapy: Open Access, Immunome Research journal, Immunology Journal, Immunooncology journal, Immunobiology journal, Therapeutic Advances in Medical Oncology, MAEDICA – A Journal of Clinical Medicine, Immunology & Cell Biology, Annals of Oncology, Future Oncology.